1. Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers;Elhalawani;Ther Clin Risk Manag,2015
2. Pazopanib: a new multiple tyrosine kinase inhibitor in the therapy of metastatic renal cell carcinoma and other solid tumors;Melichar;J BUON,2011
3. Pazopanib: approval for soft-tissue sarcoma;Nguyen;J Adv Pract Oncol,2013
4. Overview of fundamental study of pazopanib in cancer;Zhao;Thorac Cancer,2014
5. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02);Iwamoto;Neuro Oncol,2010